Oramed Pharma (ORMP) Issues Letter to Shareholders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Marvell shares jump after giving Google warrants amid custom chip deal
Oramed Letter to Shareholders
February 20, 2024 8:30 AM ESTInitiating Phase 3 oral insulin trial in the United States under a new protocol JV with Chinese Partner, HTITScilex Senior Secured NotePeriTech Asset Purchase & Strategic Out-licensingÂ
NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Oramed Pharmaceuticals... More
